-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Y-mAbs Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2024.
- Y-mAbs Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -35.6 %, a 17.6% decline year-over-year.
- Y-mAbs Therapeutics, Inc. annual Operating Margin for 2024 was -35.6 %, a 17.6% decline from 2023.
- Y-mAbs Therapeutics, Inc. annual Operating Margin for 2023 was -30.3 %, a 79.2% increase from 2022.
- Y-mAbs Therapeutics, Inc. annual Operating Margin for 2022 was -145 %, a 56.1% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)